So it can't be said for certain if his idea was right or wrong
The evidence was based on experimental data only briefly described in the patent and included models of: gastric ulcers, heart damage, liver damage, pancreatic injury, kidney damage, experimental diabetes, fever, edema, rhinitis, bone fracture, burns, skin wounds, hypersensitivity reactions, pupil dilation, colon injury, tumour growth, radiation injury, red blood cell development, fertility and lactation, tooth damage, several types of central and peripheral nerve damage, and survival from infection with Trichinosis (i.e., tapeworms) as well as several viruses
On the research peptide market, BPC-157 remains one of the most requested and most documented in preclinical literature, just behind TB-500 and CJC-1295/Ipamorelin
Additionally, Dihexa supports brain plasticity, which is the brains ability to adapt and form new neural connections
improved collagen organization and tensile strength (PMID: 21030672) Gastrointestinal: Protection against NSAID-induced ulcers, IBD models, fistula healing in preclinical studies (PMID: 31158953) Nerve: Enhanced sciatic nerve regeneration
It is sold legally as a research chemical